- Release Date: 18/10/21 09:28
- Summary: Clinical utility study shows benefit of PromarkerD testing
- Price Sensitive: Yes
- Download Document 486.39KB
Ann: Clinical utility study shows benefit of PromarkerD testing
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
0.010(1.45%) |
Mkt cap ! $91.70M | |||
| Open | High | Low | Value | Volume |
| 69.0¢ | 70.5¢ | 68.5¢ | $29.16K | 41.85K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12777 | 70.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 71.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.12pm 08/11/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |